Trial Profile
Pregabalin in Partial Seizures (PREPS) Extension Study: An 18-Month Follow-on Open-Label, International, Multicenter Add-on Therapy Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Jan 2021
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- Acronyms PREPS-EXT
- Sponsors Pfizer; Viatris Inc
- 28 Jan 2008 Status changed from recruiting to completed.
- 20 Nov 2005 New trial record.